Differential response to DNA damage may explain different cancer susceptibility between small and large intestine.
Although large intestine (LI) cancer is the second-leading cause of cancer-related deaths in the United States, small intestine (SI) cancer is relatively rare. Because oxidative DNA damage is one possible initiator of tumorigenesis, we investigated if the SI is protected against cancer because of a more appropriate response to oxidative DNA damage compared with the LI. Sixty rats were allocated to three treatment groups: 3% dextran sodium sulfate (DSS, a DNA-oxidizing agent) for 48 hrs, withdrawal (DSS for 48 hrs + DSS withdrawal for 48 hrs), or control (no DSS). The SI, compared with the LI, showed greater oxidative DNA damage (P < 0.001) as determined using a quantitative immunohistochemical analysis of 8-oxodeoxyguanosine (8-oxodG). The response to the DNA adducts in the SI was greater than in the LI. The increase of TdT-mediated dUTP-biotin nick end labeling (TUNEL)-positive apoptosis after DSS treatment was greater in the SI compared with the LI (P < 0.001), and there was a positive correlation (P = 0.031) between DNA damage and apoptosis in the SI. Morphologically, DSS caused an extensive loss of crypt structure shown in lower crypt height (P = 0.006) and the number of intact crypts (P = 0.0001) in the LI, but not in the SI. These data suggest that the SI may be more protected against cancer by having a more dynamic response to oxidative damage that maintains crypt morphology, whereas the response of the LI makes it more susceptible to loss of crypt architecture. These differential responses to oxidative DNA damage may contribute to the difference in cancer susceptibility between these two anatomic sites of the intestine.
Hong
Mee Young
MY
Department of Nutrition and Food Science, Texas A&M University, TX 77843-2253, USA.
Turner
Nancy D
ND
Carroll
Raymond J
RJ
Chapkin
Robert S
RS
Lupton
Joanne R
JR
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000818:Animals; D017209:Apoptosis; D049109:Cell Proliferation; D004247:DNA / Q000187:drug effects; D018736:DNA Adducts / Q000378:metabolism; D004249:DNA Damage; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000032:analysis; D016264:Dextran Sulfate / Q000633:toxicity; D004198:Disease Susceptibility / Q000209:etiology; D007414:Intestinal Neoplasms / Q000235:genetics*; D007420:Intestine, Large / Q000276:immunology / Q000473:pathology*; D007421:Intestine, Small / Q000276:immunology / Q000473:pathology*; D008297:Male; D018384:Oxidative Stress; D051381:Rats
D018736:DNA Adducts; D000080242:8-Hydroxy-2'-Deoxyguanosine; D004247:DNA; D016264:Dextran Sulfate; D003849:Deoxyguanosine